Point of Care Diagnostics Market to Reach US$ 87.9 Billion by 2035 Amid Rising Demand for Rapid Testing Solutions

The global point-of-care (POC) diagnostics market is poised for significant expansion, projected to rise from US$ 44.7 billion in 2025 to US$ 87.9 billion by 2035, reflecting a steady compound annual growth rate (CAGR) of 7% over the forecast period.

The growing prevalence of chronic and infectious diseases, combined with an increasing demand for rapid, decentralized diagnostic testing, continues to fuel adoption across healthcare systems worldwide.

The escalating need for near-patient and home-based diagnostics devices contributed significantly to defining the sector's development landscape.

Additionally, the escalating fears about infectious and chronic ailments assisted in initiating investment in new-generation diagnostic devices, boosting the sector's growth in developed as well as developing countries.

Moving forward to 2025, the industry is set to continue growth as technological integration continues to improve point-of-care testing accuracy and efficiency.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7266

Key Takeaways from Market Study:

1. The global point-of-care diagnostics market is projected to reach US$ 44.7 billion in 2025.
2. The market is expected to grow at a CAGR of 7% from 2025 to 2035.
3. By 2035, the market is forecasted to reach US$ 87.9 billion.
4. The U.S. market is anticipated to expand at a 7.3% CAGR through 2035.
5. India is projected to grow at a 7.8% CAGR during the forecast period.
6. China, Germany, UK, Japan, and South Korea show growth rates between 7.2% and 7.6% CAGR.

Leading Players Driving Innovation in the Point of Care Diagnostics Market:

Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers (Siemens AG), Danaher Corporation (Beckman Coulter, Cepheid, Radiometer), Thermo Fisher Scientific Inc., BD (Becton, Dickinson and Company), bioMérieux SA, QuidelOrtho, Johnson & Johnson Services Inc., Nova Biomedical, Cardinal Health Inc., Bio-Rad Laboratories Inc., Sysmex Corporation, EKF Diagnostics (part of Citadel Group), Sekisui Diagnostics.

Key Growth Drivers:

The rising need for fast, accurate diagnostics-particularly in emergency, outpatient, and home settings-is a primary driver behind the market's growth. Demand is intensifying for portable and easy-to-use testing devices capable of delivering real-time results for a range of medical conditions, including glucose monitoring, infectious diseases, and cardiometabolic disorders.

Ongoing innovations in molecular diagnostics, microfluidic technology, and lateral flow assay platforms are expected to further enhance the capabilities and accessibility of point-of-care solutions over the next decade.

Platform Advancements:

Among the key diagnostic platforms, lateral flow assays remain the most widely used due to their simplicity and low cost. However, microfluidics and molecular diagnostics are gaining ground, offering advanced features such as multiplexing and improved sensitivity.

Immunoassays also continue to play a vital role in rapid diagnostic screening. These platforms collectively cater to a broad spectrum of clinical applications, from chronic disease management to infectious disease detection.

Application Trends:

By application, glucose monitoring remains the largest segment, driven by the global diabetes burden. However, infectious disease testing products are witnessing the fastest growth, supported by global health concerns and increased pandemic preparedness.

Cardiometabolic, pregnancy and fertility, hematology, cholesterol, urinalysis, and drugs-of-abuse testing also represent key segments with robust market participation.

Browse Full Report: https://www.factmr.com/report/point-of-care-diagnostics-market

More Valuable Insights on Offer:

Fact.MR, in its new offering, presents an unbiased analysis of the global Point of Care Diagnostics Market, presenting historical data for 2020 to 2024 and forecast statistics for 2025 to 2035.

The point-of-care diagnostics market is segmented based on platform, application, end user, and region. By platform, the market includes lateral flow assays, dipsticks, microfluidics, molecular diagnostics, immunoassays, and others.

In terms of application, the market comprises glucose monitoring products, cardiometabolic monitoring products, infectious disease testing products, pregnancy and fertility testing products, urinalysis testing products, cholesterol testing products, hematology testing products, drugs-of-abuse testing products, and other applications.

The end-user segment is categorized into hospitals, diagnostic laboratories, clinics or physician offices, home care, and others. Geographically, the market is divided into North America, Latin America, Europe, East Asia, South Asia & Oceania, and the Middle East and Africa (MEA).

Check out More Related Studies Published by Fact.MR Research:

Cardiac POC Testing Devices Market - https://www.factmr.com/report/cardiac-poc-testing-devices-market

Pregnancy Point of Care Testing Market - https://www.factmr.com/report/3560/pregnancy-point-of-care-testing-market

Critical Care Diagnostics Market - https://www.factmr.com/report/critical-care-diagnostics-market

Paper-Based Diagnostic Test Kit Market - https://www.factmr.com/report/583/paper-based-diagnostic-test-kits-market

Contact Us:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team : sales@factmr.com

About Us:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.

This release was published on openPR.